Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules
Open Access
- 25 February 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (8), 2002-2014
- https://doi.org/10.1158/0008-5472.can-20-2929
Abstract
Pancreatic adenocarcinoma (PDAC) epitomizes a deadly cancer driven by abnormal KRAS signaling. Here, we show that the eIF4A RNA helicase is required for translation of key KRAS signaling molecules and that pharmacological inhibition of eIF4A has single-agent activity against murine and human PDAC models at safe dose levels. EIF4A was uniquely required for the translation of mRNAs with long and highly structured 5′ untranslated regions, including those with multiple G-quadruplex elements. Computational analyses identified these features in mRNAs encoding KRAS and key downstream molecules. Transcriptome-scale ribosome footprinting accurately identified eIF4A-dependent mRNAs in PDAC, including critical KRAS signaling molecules such as PI3K, RALA, RAC2, MET, MYC, and YAP1. These findings contrast with a recent study that relied on an older method, polysome fractionation, and implicated redox-related genes as eIF4A clients. Together, our findings highlight the power of ribosome footprinting in conjunction with deep RNA sequencing in accurately decoding translational control mechanisms and define the therapeutic mechanism of eIF4A inhibitors in PDAC. These findings document the coordinate, eIF4A-dependent translation of RAS-related oncogenic signaling molecules and demonstrate therapeutic efficacy of eIF4A blockade in pancreatic adenocarcinoma.Keywords
Other Versions
Funding Information
- NIH NCI Memorial Sloan Kettering Cancer Center (R01CA183876-03, R01 CA207217-04, R01CA190384-05, P50 CA217694-02, P50 CA192937-04)
- MSKCC Core Grant (P30 CA008748)
- NIH (R01CA204228)
- NIH (U54 OD020355-01)
- ETH Zurich (K12 CA184746)
- NIH (R35 GM124998)
- CCSG (P30 CA08748)
- NCI (P30 CA08748)
This publication has 56 references indexed in Scilit:
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesNature, 2012
- The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragmentsNature Protocols, 2012
- Synthesis of Rocaglamide Hydroxamates and Related Compounds as Eukaryotic Translation Inhibitors: Synthetic and Biological StudiesJournal of Medicinal Chemistry, 2011
- Duplex Unwinding and ATPase Activities of the DEAD-Box Helicase eIF4A Are Coupled by eIF4G and eIF4BJournal of Molecular Biology, 2011
- FIMO: scanning for occurrences of a given motifBioinformatics, 2011
- MEME SUITE: tools for motif discovery and searchingNucleic Acids Research, 2009
- Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome ProfilingScience, 2009
- Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma modelJCI Insight, 2008
- An RNA G-quadruplex in the 5′ UTR of the NRAS proto-oncogene modulates translationNature Chemical Biology, 2007
- Both p16 Ink4a and the p19 Arf -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouseProceedings of the National Academy of Sciences, 2006